• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Fast Radius Expands Leadership Team and Appoints New General Counsel and Chief Accounting Officer

    3/15/22 8:00:00 AM ET
    $BAX
    $CNHI
    $FSRD
    $GRPN
    Medical/Dental Instruments
    Health Care
    Construction/Ag Equipment/Trucks
    Industrials
    Get the next $BAX alert in real time by email

    CHICAGO, March 15, 2022 (GLOBE NEWSWIRE) -- Fast Radius, Inc. (NASDAQ:FSRD), a cloud manufacturing company, today announced it has named Erin Stone as General Counsel and Corporate Secretary, and James Erkenswick as Chief Accounting Officer. These leadership additions mark important milestones for Fast Radius' evolution as a publicly traded company. In her capacity as General Counsel and Corporate Secretary, Stone will serve as an important strategic and legal advisor to Fast Radius's board of directors and management and will oversee all legal and compliance matters for the company. In his role as Chief Accounting Officer, Erkenswick will have leadership over the preparation of all financial accounting, audit and internal controls matters, and the preparation of Fast Radius's external reporting materials.

    "Erin and Jim bring invaluable experience leading corporate governance and compliance for fast-growing, public companies, bringing additional expertise and leadership as we continue to scale our business in the near-term," said Lou Rassey, Co-Founder and CEO of Fast Radius. "They both possess an entrepreneurial spirit and proven cross-functional leadership ability. We are thrilled to have them join the Fast Radius leadership team."

    Stone has more than 15 years of legal experience working with technology-driven businesses and public companies. Prior to Fast Radius, Stone served as Vice President and Deputy General Counsel, Corporate and Securities at Groupon (NASDAQ:GRPN), where she was a key advisor and trusted partner to their executive team and Board of Directors. She also brings strong technical expertise in corporate governance and securities, and broad commercial experience from her tenure at Groupon and as a corporate partner at Winston and Strawn LLP.

    As Chief Accounting Officer, Erkenswick brings more than 20 years of accounting and finance experience for industrial companies, with deep knowledge of SEC reporting and GAAP compliance. Most recently, Erkenswick served as Vice President, Assistant Controller at Baxter International Inc. (NYSE:BAX), where he held positions leading financial reporting and corporate accounting. Prior to joining Baxter International, Erkenswick held accounting leadership positions at US LBM, CNH Industrial (NYSE:CNHI), and Ace Hardware.

    ABOUT FAST RADIUS

    Fast Radius, Inc. is a leading cloud manufacturing and digital supply chain company. The Fast Radius Cloud Manufacturing Platform™ provides software applications and manufacturing solutions that help engineers design, make, and fulfill commercial-grade parts, when and where they are needed. This enables companies to manufacture and ship parts easily, flexibly, and sustainably. Founded in 2017, Fast Radius, Inc. is headquartered in Chicago with offices in Atlanta, Louisville, and Singapore, and microfactories in Chicago and at the UPS Worldport facility in Louisville, KY. To learn more about Fast Radius and how its digital manufacturing capabilities are helping companies, please visit www.fastradius.com or connect with us on LinkedIn at www.linkedin.com/company/fastradius or Twitter @fastradius.

    CONTACT

    Kelly Smith

    MSL U.S.

    [email protected];

    646-500-7654



    Primary Logo

    Get the next $BAX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BAX
    $CNHI
    $FSRD
    $GRPN

    CompanyDatePrice TargetRatingAnalyst
    Baxter International Inc.
    $BAX
    2/26/2025$42.00Buy
    Goldman
    Baxter International Inc.
    $BAX
    2/24/2025Hold → Buy
    Argus
    Baxter International Inc.
    $BAX
    2/20/2025$39.00Overweight
    Barclays
    Baxter International Inc.
    $BAX
    7/15/2024$39.00 → $30.00Equal-Weight → Underweight
    Morgan Stanley
    Groupon Inc.
    $GRPN
    7/10/2024$22.00Outperform
    Northland Capital
    Baxter International Inc.
    $BAX
    5/30/2024$36.00Neutral
    Goldman
    Baxter International Inc.
    $BAX
    5/10/2024$40.00Buy → Hold
    TD Cowen
    CNH Industrial N.V.
    $CNHI
    4/22/2024Buy → Neutral
    BofA Securities
    More analyst ratings

    $BAX
    $CNHI
    $FSRD
    $GRPN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • October 18, 2024 - FDA Roundup: October 18, 2024

      For Immediate Release: October 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  This week, FDA continues ongoing efforts to increase access and supply of IV and peritoneal dialysis (PD) fluids following Hurricane Helene-related damage to Baxter International Inc.’s facility in Marion, North Carolina. Specifically, FDA acted quickly to c

      10/18/24 4:16:25 PM ET
      $NVCR
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    SEC Filings

    See more
    • Baxter International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

      8-K - BAXTER INTERNATIONAL INC (0000010456) (Filer)

      7/7/25 8:51:26 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Groupon Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

      8-K - Groupon, Inc. (0001490281) (Filer)

      7/2/25 5:21:11 PM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • Groupon Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

      8-K - Groupon, Inc. (0001490281) (Filer)

      6/18/25 7:29:31 AM ET
      $GRPN
      Advertising
      Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors

      Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is g

      7/17/25 4:15:00 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • CNH to announce 2025 Q2 financial results on August 1

      CNH to announce 2025 Q2 financial results on August 1 Basildon, July 17, 2025 CNH (NYSE:CNH) will release its financial results for the Second Quarter of 2025 on Friday, August 1, 2025. A live listen-only webcast of the financial results conference call will begin at 9:00 a.m. ET on the same day. It will be accessible here: bit.ly/CNH_Q2_2025 For those unable to participate in the live session, a replay will remain archived in the Investor Relations section of the corporate website (www.cnh.com) for 12 months. Those interested in participating in the Q&A session should connect via telephone at least 10 minutes prior to the start of the event. Dial-in numbers: U.S. Toll-Free: +1 (800) 7

      7/17/25 6:30:00 AM ET
      $CNH
      $CNHI
      Construction/Ag Equipment/Trucks
      Industrials
    • Baxter Declares Quarterly Dividend

      Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched po

      7/14/25 4:40:00 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Harinstein Jason bought $159,150 worth of shares (15,000 units at $10.61), increasing direct ownership by 37% to 55,658 units (SEC Form 4)

      4 - Groupon, Inc. (0001490281) (Issuer)

      8/9/24 4:38:58 PM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • Senkypl Dusan bought $3,069,745 worth of shares (323,344 units at $9.49) (SEC Form 4)

      4 - Groupon, Inc. (0001490281) (Issuer)

      11/20/23 6:27:56 PM ET
      $GRPN
      Advertising
      Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Ponrt Jiri converted options into 40,968 shares, increasing direct ownership by 26% to 198,336 units (SEC Form 4)

      4 - Groupon, Inc. (0001490281) (Issuer)

      6/23/25 8:24:18 PM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • CEO Senkypl Dusan converted options into 109,250 shares, increasing direct ownership by 20% to 663,761 units (SEC Form 4)

      4 - Groupon, Inc. (0001490281) (Issuer)

      6/23/25 8:23:48 PM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • Director Leonsis Theodore was granted 13,343 shares, increasing direct ownership by 7% to 218,600 units (SEC Form 4)

      4 - Groupon, Inc. (0001490281) (Issuer)

      6/17/25 3:40:56 PM ET
      $GRPN
      Advertising
      Consumer Discretionary

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Goldman resumed coverage on Baxter with a new price target

      Goldman resumed coverage of Baxter with a rating of Buy and set a new price target of $42.00

      2/26/25 7:01:30 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Baxter upgraded by Argus

      Argus upgraded Baxter from Hold to Buy

      2/24/25 10:10:46 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • Barclays resumed coverage on Baxter with a new price target

      Barclays resumed coverage of Baxter with a rating of Overweight and set a new price target of $39.00

      2/20/25 8:18:14 AM ET
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Financials

    Live finance-specific insights

    See more
    • Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors

      Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31, 2025 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I156238 to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter's website at www.baxter.com. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is g

      7/17/25 4:15:00 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care
    • CNH to announce 2025 Q2 financial results on August 1

      CNH to announce 2025 Q2 financial results on August 1 Basildon, July 17, 2025 CNH (NYSE:CNH) will release its financial results for the Second Quarter of 2025 on Friday, August 1, 2025. A live listen-only webcast of the financial results conference call will begin at 9:00 a.m. ET on the same day. It will be accessible here: bit.ly/CNH_Q2_2025 For those unable to participate in the live session, a replay will remain archived in the Investor Relations section of the corporate website (www.cnh.com) for 12 months. Those interested in participating in the Q&A session should connect via telephone at least 10 minutes prior to the start of the event. Dial-in numbers: U.S. Toll-Free: +1 (800) 7

      7/17/25 6:30:00 AM ET
      $CNH
      $CNHI
      Construction/Ag Equipment/Trucks
      Industrials
    • Baxter Declares Quarterly Dividend

      Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on October 1, 2025, to stockholders of record as of August 29, 2025. The indicated annual dividend rate is $0.68 per share of common stock. About Baxter At Baxter, we are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician's office and other sites of care. For nearly a century, our customers have counted on us as a vital and trusted partner. And every day, millions of patients and healthcare providers rely on our unmatched po

      7/14/25 4:40:00 PM ET
      $BAX
      Medical/Dental Instruments
      Health Care

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Leadership Updates

    Live Leadership Updates

    See more
    • Baxter Appoints Andrew Hider Chief Executive Officer

      Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a member of its board of directors. Mr. Hider will assume his responsibilities at Baxter no later than Sept. 3, 2025, or an earlier date pending completion of his current employment commitments. Brent Shafer, who has served as chair and interim CEO since February 2025, will then transition to independent chair of the Baxter Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250706840140/en/Andrew Hider Appointed Baxter's Next CEO Since 2017, Mr. Hider has served as

      7/7/25 8:35:00 AM ET
      $ATS
      $BAX
      Industrial Machinery/Components
      Industrials
      Medical/Dental Instruments
      Health Care
    • Amerant Bancorp Announces Appointment of Two New Board Members

      Amerant Bancorp Inc. (NYSE:AMTB) ("Amerant" or "the Company") and its subsidiary, Amerant Bank, N.A. (the "Bank"), today announced the appointment of two accomplished executives, Patricia "Patty" Morrison and Jack Kopnisky, to the Board of Directors of the Company and the Bank. Their addition reflects the Company's continued commitment to strategic growth and further strengthening of the Board of Directors and executive management. "We are delighted to welcome both Patty and Jack to our Board of Directors," said Jerry Plush, Chairman and CEO of Amerant and the Bank. "Patty's deep technology leadership and extensive board expertise, paired with Jack's enviable experience in leading high pe

      6/24/25 9:20:00 AM ET
      $AMTB
      $BAX
      $WBS
      Major Banks
      Finance
      Medical/Dental Instruments
      Health Care
    • CNH announces Global Leadership Team appointment

      CNH announces Global Leadership Team appointment Basildon, March 17, 2025 CNH (NYSE:CNH) today announces the appointment of Cameron Batten as Chief Communications Officer effective March 31, 2025. Mr. Batten will join the Company's Global Leadership Team (GLT), which is empowered to carry out the fast and effective delivery of CNH's strategic priorities for profitable long-term growth. Cameron Batten has over 25 years of experience in communications across media and institutional/government relations, brand marketing, corporate reputation, employee engagement and social impact with top-tier consumer brands. Ahead of joining CNH, he served as Chief Communications Officer at Volkswage

      3/17/25 4:30:00 PM ET
      $CNH
      $CNHI
      Construction/Ag Equipment/Trucks
      Industrials

    $BAX
    $CNHI
    $FSRD
    $GRPN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Groupon Inc.

      SC 13G - Groupon, Inc. (0001490281) (Subject)

      12/13/24 10:39:00 AM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G filed by Groupon Inc.

      SC 13G - Groupon, Inc. (0001490281) (Subject)

      12/6/24 2:12:18 PM ET
      $GRPN
      Advertising
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Groupon Inc.

      SC 13G/A - Groupon, Inc. (0001490281) (Subject)

      11/14/24 6:51:01 PM ET
      $GRPN
      Advertising
      Consumer Discretionary